Loading stock data…
Loading stock data…
Earnings reportIn 14 days
Wednesday, July 29 · EPS est. 0.4447
Confirmed dates from data providers — they can still change. Information only, not investment advice.
US$22.12
Get one email when INVA crosses your level. Checked every 15 minutes during market hours.
▲ +0.23 (1.05%)up today
USD · data via Finnhub · delayed/cached up to 1–5 min
Get an AI-written, balanced deep-dive — performance, valuation, technicals, and the bull vs. bear case. Sign in to get started.
RSI (14-day)
46.2
NeutralAbove 70 can signal overbought; below 30, oversold.
MACD
-0.17
Bearish momentumMACD below its signal line (-0.09).
50-day average
22.42
Price belowShort-term trend reference.
200-day average
21.32
Price aboveLong-term trend reference.
Daily values · indicators are descriptive, not trading advice
Healthcare · Biotechnology
Innoviva Inc. is an innovative pharmaceutical company, focusing primarily on managing royalty portfolios that originate from collaborations with external partners. This asset plays a significant role in the healthcare sector, specifically within the pharmaceuticals and biotechnology industries. The company is involved in the development and commercialization of products in the respiratory disease space, notably co-developing medicines that address chronic obstructive pulmonary disease (COPD) and…
www.inva.com4 strong buy · 5 buy · 1 hold · 1 sell · 0 strong sell (11 analysts, 2026-07-01)
4 strong buy · 5 buy · 1 hold · 1 sell · 0 strong sell (11 analysts, 2026-06-01)
4 strong buy · 5 buy · 1 hold · 1 sell · 0 strong sell (11 analysts, 2026-05-01)
4 strong buy · 5 buy · 1 hold · 1 sell · 0 strong sell (11 analysts, 2026-04-01)
| Quarter | Estimate | Actual | Result |
|---|---|---|---|
| 2026-05-06 | 0.43 | 0.47 | ✓ Beat |
| 2026-02-25 | 0.43 | 0.47 | ✓ Beat |
| 2026-02-12 | 1.03 | 1.07 | ✓ Beat |
| 2026-01-15 | 2.98 | 3.14 | ✓ Beat |
| 2026-01-07 | 1.94 | 2.13 | ✓ Beat |
| 2025-11-05 | 0.39 | 0.38 | ✗ Miss |
| 2025-08-06 | 0.5 | 0.77 | ✓ Beat |
| 2025-05-07 | 0.29 | -0.74 | ✗ Miss |
Companies in the same industry, via Finnhub